PHGDH-IN-3

SKU: orb1744402

Description

PHGDH-IN-3 is an orally bioavailable small molecule inhibitor of phosphoglycerate dehydrogenase (PHGDH) with an IC50 of 2.8 µM. It is a research tool for investigating PHGDH's role in cancer metabolism and has been utilized in both in vitro and in vivo preclinical studies.

Research Area

Metabolism Research

Key Properties

• CAS Number: 2893778-31-7
• MW: 495.55
• Purity: 99.47% (May vary between batches)
• Formula: C₂₄H₁₈FN₃O₄S₂
• SMILES: N(C(=O)C1=CC=C(S(NC2=CC(C(C)=O)=CC=C2)(=O)=O)C=C1)C3=NC(=CS3)C4=CC(F)=CC=C4
• Target: Dehydrogenase
• Solubility: 10% DMSO+90% Corn Oil:5 mg/mL (10.09 mM);DMSO:90 mg/mL (181.62 mM)

Bioactivity

• Target IC50:
  PHGDH:2.8 μM|PHGDH:2.33 μM
• In Vivo:
  PHGDH-IN-3 (compound D8) (1, 3 mg/kg; p.o., i.v.) exhibits excellent in vivo pharmacokinetic properties. Additionally, PHGDH-IN-3 (12.5, 25, 50 mg/kg; i.p.; once daily for 31 days) demonstrated significant antitumor effects in a PC9 xenograft mouse model.
  Read more...
• In Vitro:
  PHGDH-IN-3 (compound D8) exhibits strong enzymatic inhibitory activity with an IC50 value of 2.8 μM and demonstrates high binding affinity for PHGDH protein with a Kd value of 2.33 μM. It is particularly effective against cell lines with amplified or overexpressed PHGDH genes and restricts de novo serine synthesis from glucose in MDA-MB-468 cells.
  Read more...

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

PHGDH

Compound Identifiers

PubChem CID

166638116